November 17, 2017
A combination of oral probiotic formulations for atopic dermatitis in young patients was associated with improved SCORAD index scores and reduced use of topical corticosteroids, according to recent study data.
The 12-week, randomized, double-blind, placebo-controlled study included 50 patients accrued at a single outpatient center in Spain. Eligible participants were aged 4 to 17 years and were accrued between March and June of 2016. Clinicians stratified patient groups by sex, age and age at onset of atopic dermatitis.